VCP
TDOC icon

Verus Capital Partners’s Teladoc Health TDOC Stock Holding History

Verus Capital Partners’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,585
Closed -$224K – 324
2022
Q1 		$224K Buy
+4,585
New +$330K 0.03% 285

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Verus Capital Partners's TDOC Position: Q2 2022 in Review

Verus Capital Partners sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 4,585 shares — an estimated $224K sold.

Verus Capital Partners first reported a position in TDOC in Q1 2022 and held it in 1 quarter. The position peaked at $224K in Q1 2022. 550 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Verus Capital Partners reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Verus Capital Partners sold 4,585 Teladoc Health shares in Q2 2022, an estimated $224K.
  • Verus Capital Partners first reported a position in Teladoc Health in Q1 2022 and held it in 1 quarter.
  • Verus Capital Partners's Teladoc Health position peaked at $224K in Q1 2022.
  • 550 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Verus Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.